Divergent Rifamycin Susceptibilities of Clostridium difficile Strains in Canada and Italy and Predictive Accuracy of Rifampin Etest for Rifamycin Resistance

Fidaxomicin versus Vancomycin forClostridium difficileInfection

(2011) Thomas J. Louie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of Death afterClostridium difficileInfection: A Report on 128 Strain‐Typed Cases from a Teaching Hospital in the United Kingdom

(2010) Vhairi Wilson et al.   CLINICAL INFECTIOUS DISEASES

In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas

(2010) Z-D Jiang et al.   JOURNAL OF CLINICAL PATHOLOGY

High Frequency of Rifampin Resistance Identified in an EpidemicClostridium difficileClone from a Large Teaching Hospital

(2009) Scott R. Curry et al.   CLINICAL INFECTIOUS DISEASES

Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases

(2009) Hoonmo L Koo et al.   CURRENT OPINION IN GASTROENTEROLOGY

Rifamycin Antibiotics for Treatment of Clostridium difficile–Associated Diarrhea

(2008) Kevin W Garey et al.   ANNALS OF PHARMACOTHERAPY

Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile

(2008) J. R. O'Connor et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection

(2008) T. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY